Start for free
Start for free
DC

Downsview Capital

North America, Illinois, United States, Deerfield

Description

Downsview Capital, Inc. is a Illinois-based investment advisor that manages the private equity funds including Cranshire Capital, L.P.

Investor Profile

Downsview Capital has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (67%)
  • Post Ipo Equity (33%)

Country Focus

  • United States (67%)
  • China (17%)
  • United Kingdom (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Electronics
  • Hardware
  • Management Information Systems
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Downsview Capital frequently co-invest with?

Iroquois Capital
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 6
Hartz Mountain Industries
Hartz Mountain Industries
North America, New Jersey, United States, Secaucus
Co-Investments: 1
Dafna Capital Management
Dafna Capital Management
North America, California, United States, Los Angeles
Co-Investments: 2
Heights Capital Management
Heights Capital Management
North America, California, United States, San Francisco
Co-Investments: 2
ArmaVir Partners
ArmaVir Partners
North America, New York, United States, New York
Co-Investments: 2
Cowen Group
Cowen Group
North America, New York, United States, New York
Co-Investments: 1
AC
Ayer Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
KP
Kingsbrook Partners
North America, New York, United States, New York
Co-Investments: 1
SP
Straus Partners
Europe, Midtjylland, Denmark, Holstebro
Co-Investments: 1
Highbridge Capital Management
Highbridge Capital Management
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Downsview Capital?

Cascadian Therapeutics

Seattle, Washington, United States

Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.

BiotechnologyHealth CareTherapeutics
Post Ipo EquitySep 24, 2010
Amount Raised: $14,900,000
Soligenix

Princeton, New Jersey, United States

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownJul 2, 2010
Amount Raised: $5,904,277
SinoHub

Shenzhen, Guangdong, China

SinoHub was a one-stop-shop for all electronic component supply chain services.

ElectronicsHardwareManagement Information SystemsManufacturingSoftwareSupply Chain Management
Series UnknownFeb 24, 2010
Amount Raised: $4,610,000
Agenus

Lexington, Massachusetts, United States

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.

BiotechnologyMedicalMedical DeviceTherapeutics
Post Ipo EquityAug 4, 2009
Amount Raised: $10,000,000
EUSA Pharma

Hemel Hempstead, Hertford, United Kingdom

EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series UnknownDec 13, 2005
Amount Raised: $12,530,000
Pharmacopeia

Cranbury, New Jersey, United States

Pharmacopeia, a biopharmaceutical company, engages in the discovery and development of therapeutics to address significant medical needs.

BiopharmaBiotechnologyPharmaceutical
Series UnknownJul 27, 2005
Amount Raised: $7,630,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator